Literature DB >> 7719221

Second cancers following oral and pharyngeal cancer: patients' characteristics and survival patterns.

G L Day1, W J Blot, R E Shore, J B Schoenberg, B A Kohler, R S Greenberg, J M Liff, S Preston-Martin, D F Austin, J K McLaughlin.   

Abstract

A survey was made of second primary cancers among patients who were enrolled in a large case-control investigation of oral and pharyngeal cancer, hereafter called oral cancer, during 1984-1985 in four areas of the United States. Among the original 1090 patients with oral cancer (nearly all squamous cell carcinomas), 107 developed a second cancer (one-half of them squamous cell) by the end of follow-up in June 1989 (average follow-up 2.6 years), with 69% occurring in the oral cavity, pharynx, oesophagus, larynx or lung. Rates of second tumours varied by age and socioeconomic status, but not sex or race, and were higher among those whose initial cancer was localised, even after adjusting for their longer survival. Long-term survival was lower among those with second cancers. Conditional on surviving for 2 years, the survival at 5 years was under 50% and nearly 70%, respectively, for those with versus those without a second cancer in the first 2 years. These findings confirm the exceptionally high rate of second cancers (especially of the aerodigestive tract) following oral cancer, describe the clinical and pathological features of patients with multiple cancers and indicate the importance of preventive measures.

Entities:  

Mesh:

Year:  1994        PMID: 7719221     DOI: 10.1016/0964-1955(94)90016-7

Source DB:  PubMed          Journal:  Eur J Cancer B Oral Oncol        ISSN: 0964-1955


  6 in total

1.  Second primary esophageal or lung cancer in patients with head and neck carcinoma in Taiwan: incidence and risk in relation to primary index tumor site.

Authors:  Min-Chi Chen; Ping-Tsung Chen; Chunghuang Hubert Chan; Cheng-Ta Yang; Chih-Cheng Chen; Cih-En Huang; Chang-Hsien Lu; Kuan-Der Lee
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-20       Impact factor: 4.553

2.  Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer.

Authors:  Luc G T Morris; Andrew G Sikora; Richard B Hayes; Snehal G Patel; Ian Ganly
Journal:  Cancer Causes Control       Date:  2011-02-15       Impact factor: 2.506

3.  Efficacy of Varunadi Ghritha (polyherbal compound) in treated head and neck cancer cases as a biological response modifier.

Authors:  Divya Ravindran; Indhu Hariharan; Richard Muwonge; Rejnish R Kumar; M Radhakrishna Pillai; Kunnambath Ramadas
Journal:  Ayu       Date:  2014-04

4.  Incidence and Outcomes of Patients With Oral Cavity Squamous Cell Carcinoma and Fourth Primary Tumors: A Long-term Follow-up Study in a Betel Quid Chewing Endemic Area.

Authors:  Mohamad Adel; Chun-Ta Liao; Li-Yu Lee; Chuen Hsueh; Chien-Yu Lin; Kang-Hsing Fan; Hung-Ming Wang; Shu-Hang Ng; Chih-Hung Lin; Chung-Kan Tsao; Shiang-Fu Huang; Chung-Jan Kang; Ku-Hao Fang; Yu-Chien Wang; Kai-Ping Chang; Tuan-Jen Fang; Lan Yan Yang; Tzu-Chen Yen
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

5.  The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period.

Authors:  Kuan-Der Lee; Chang-Hsien Lu; Ping-Tsung Chen; Chunghuang Hubert Chan; Jen-Tsun Lin; Cih-En Huang; Chih-Cheng Chen; Min-Chi Chen
Journal:  BMC Cancer       Date:  2009-10-20       Impact factor: 4.430

Review 6.  Smoking cessation care among patients with head and neck cancer: a systematic review.

Authors:  Kristen McCarter; Úrsula Martínez; Ben Britton; Amanda Baker; Billie Bonevski; Gregory Carter; Alison Beck; Chris Wratten; Ashleigh Guillaumier; Sean A Halpin; Luke Wolfenden
Journal:  BMJ Open       Date:  2016-09-20       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.